Twist Bioscience Corp. (TWST)
144.49
-3.67
(-2.48%)
USD |
NASDAQ |
Oct 15, 16:00
143.84
-0.65
(-0.45%)
After-Hours: 20:00
Twist Bioscience Cash from Operations (TTM) : -53.07M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -53.07M |
| March 31, 2026 | -55.59M |
| December 31, 2025 | -51.01M |
| September 30, 2025 | -47.63M |
| June 30, 2025 | -51.13M |
| March 31, 2025 | -56.11M |
| December 31, 2024 | -62.55M |
| September 30, 2024 | -64.09M |
| June 30, 2024 | -69.48M |
| March 31, 2024 | -86.51M |
| December 31, 2023 | -111.38M |
| September 30, 2023 | -142.47M |
| June 30, 2023 | -123.04M |
| March 31, 2023 | -133.75M |
| December 31, 2022 | -131.80M |
| Date | Value |
|---|---|
| September 30, 2022 | -124.38M |
| June 30, 2022 | -157.92M |
| March 31, 2022 | -151.76M |
| December 31, 2021 | -133.96M |
| September 30, 2021 | -112.24M |
| June 30, 2021 | -102.64M |
| March 31, 2021 | -98.15M |
| December 31, 2020 | -132.27M |
| September 30, 2020 | -142.26M |
| June 30, 2020 | -140.41M |
| March 31, 2020 | -139.02M |
| December 31, 2019 | -101.17M |
| September 30, 2019 | -87.94M |
| June 30, 2019 | -81.28M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Intellia Therapeutics, Inc. | -346.64M |
| Beam Therapeutics, Inc. | -359.38M |
| Prime Medicine, Inc. | -156.05M |
| Absci Corp. | -108.08M |
| 10X Genomics, Inc. | 127.08M |